Showing results (1491-1500 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|October 1, 1995
Influence of leucine on intestinal baclofen absorption as a model compound of neutral alpha-aminoacidsT Cercós-Fortea, A Polache, A Nácher, et al.Biopharmaceutics & Drug Disposition|October 1, 1995
Stability and pharmacokinetic studies of a new immunosuppressant, mycophenolate mofetil (RS-61443), in ratsN Sugioka, S H Chen, K Hayashida, et al.Biopharmaceutics & Drug Disposition|December 1, 1996
Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitorA Kiriyama, T Nishiura, M Ishino, et al.Biopharmaceutics & Drug Disposition|April 1, 1996
Dose-dependent distribution volumes of total and unbound valproate in guinea-pigs: consequence of non-linear plasma protein bindingH Y Yu, Y Z ShenBiopharmaceutics & Drug Disposition|August 1, 1996
The thermal potentiation of acetaminophen-inhibited PMN oxidative metabolism in vitroE A Shalabi, A S al-TuwaijriBiopharmaceutics & Drug Disposition|August 1, 1996
Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogsJ R Baldwin, R C Lewis, B A Phillips, et al.Biopharmaceutics & Drug Disposition|July 1, 1983
Systemic bioavailability and pharmacokinetics of methylprednisolone in patients with rheumatoid arthritis following 'high-dose' pulse administrationP K Narang, R Wilder, D C Chatterji, et al.Biopharmaceutics & Drug Disposition|July 1, 1983
Significance of ratios of different volumes of distribution in pharmacokineticsJ G WagnerBiopharmaceutics & Drug Disposition|July 1, 1983
Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in 'fast' and 'slow' acetylatorsT B Vree, C A Hekster, M Baakman, et al.Biopharmaceutics & Drug Disposition|October 1, 1983
The Wagner-Nelson method applied to a multicompartment model with zero order inputJ G WagnerPageof 214